OOIR: Observatory of International Research

Papers

(The TQCC of Archiv der Pharmazie is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2	69
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives	59
Selective cytotoxicity of ent‐kaurene diterpenoids isolated from Baccharis lateralis and Baccharis retusa (Asteraceae)	52
In vitro antiviral activity of favipiravir and its 6‐ and 3‐O‐substituted derivatives against coronavirus: Acetylation leads to improvement of antiviral activity	50
Synthesis of novel pyrimido[4,5‐b]quinoline derivatives as dual EGFR/HER2 inhibitors as anticancer agents	50
Cover Picture: Arch Pharm (1/2024)	50
What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors	44
Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin‐Resistant Endometrial Cancer Cells	43
Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, in silico studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids	42
Design, synthesis, and activity evaluation of novel multitargeted l‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease	39
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers	35
Investigating the Hepatoprotective Properties of Entresto in Hepatic Ischemia‐Reperfusion Injury in Rats: The Implication of TLR4/MYD88/NF‐KB p‐65 and PPAR‐γ/HO‐1/Nrf2 Pathways	34
Synthesis and Biological Evaluation of Novel 2‐(Piperidin‐4‐yl)‐1,2,3,4‐tetrahydroisoquinoline and 2‐(Piperidin‐4‐yl)decahydroisoquinoline Antimycotics	32
Ultra‐Fast UPLC‐MS/MS Method for the Ripretinib Quantification in the HLMs Matrix With Metabolic Stability Assessment: In‐Silico Study for Toxic Alerts and the Metabolic Lability	32
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds	31
Discovery of xanthone‐based nitric oxide donors targeting biofilm clearance	31
Combating DC‐SIGN‐mediated SARS‐CoV‐2 dissemination by glycan‐mimicking polymers	27
DCAF16‐Based Covalent Molecular Glues for Targeted Protein Degradation of Histone Deacetylases	27
Isoxazole‐Based Compounds Targeting the Taxane‐Binding Site of Tubulin	27
Fabrication of sulfobutylether‐β‐cyclodextrin/glabridin inclusion complex for promoting bioactivities	26
Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity	26
GOAT rs10096097 and CREB1 rs6740584 single nucleotide polymorphisms are associated with type 2 diabetes mellitus in Egyptians	25
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review	25
Review on the pharmacological effects and pharmacokinetics of scutellarein	25
Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells	24

Unraveling the Anticancer Activity of Sunitinib Derivatives Through Modifications in Solvent‐Exposed Regions: Synthesis, In Vitro Evaluation, and Computational Studies	23
Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)	23
Carboline Hybrids as Potential Multitarget‐Directed Anti‐Alzheimer's Disease Agents: A Comprehensive Analysis of Design Strategies and Structure–Activity Relationships	22
	21
Piperlongumine and its derivatives against cancer: A recent update and future prospective	21
Structure‐guided identification of a selective sulfonamide‐based inhibitor targeting the human carbonic anhydrase VA isoform	21
Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic K_V7 channel openers: Exploration of a nicotinamide scaffold	21
Thiazole‐based SARS‐CoV‐2 protease (COV M^pro) inhibitors: Design, synthesis, enzyme inhibition, and molecular modeling simulations	21
Aromatic linker variations in novel dopamine D₂ and D₃ receptor ligands	20
Evaluation of the effect of carvedilol orodispersible tablets on ischemia–reperfusion injury and flap viability in rats: An in vivo study	20
Cover Picture: Arch Pharm (7/2023)	20
Editorial Board: Arch Pharm (10/2023)	20
Design, synthesis and biological evaluation of (E)‐kojyl‐styryl‐sulfones: Novel recilisib hybrids as promising radioprotectors	20
Cover Picture: Arch Pharm (2/2024)	19
Issue Information: Arch Pharm (5/2025)	19
Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus‐Induced Nephrotoxicity Through Targeting the miR‐22/HMGB‐1/TLR4/MyD88/NF‐κB Trajectory	18
Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis	18
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation	18
The Therapeutic Potential of Berberine in Lung Cancer	18
Novel pyrazolo[3,4‐b]pyridine derivatives: Synthesis, structure–activity relationship studies, and regulation of the AMPK/70S6K pathway	18
Microwave‐Enhanced Synthesis of 2‐Styrylquinoline‐4‐Carboxamides With Promising Anti‐Lymphoma Activity	18
	17
Green Synthetic Strategies for Pyrazole Derivatives: A Comprehensive Review	17
The discovery of a new nonbile acid modulator of Takeda G protein‐coupled receptor 5: An integrated computational approach	17
Peripheral (E)‐2‐[(4‐hydroxybenzylidene)‐3,4‐dihydronaphthalen‐1(2H)‐one)]‐coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors	17
Liposomal formulation of model pentathiepin improves solubility and stability toward glutathione while preserving anticancer activity	17
Structural determinants of sphingosine‐1‐phosphate receptor selectivity	17
Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond	16
Uncovering chemical profiles, biological potentials, and protection effect against ECM destruction in H₂O₂‐treated HDF cells of the extracts of Stachys tundjeliensis	16
New chimeric HDAC inhibitors for the treatment of colorectal cancer	16
Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells	16
Discover the Power of Lithospermic Acid as Human Carbonic Anhydrase VA and Pancreatic Lipase Inhibitor Through In Silico and In Vitro Studies	16
Novel benzothiazole/benzothiazole thiazolidine‐2,4‐dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies	16
Combining chemical profiles and biological abilities of different extracts from Tanacetum nitens (Boiss. & Noë) Grierson using network pharmacology	16
Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors	16
Design, synthesis, and evaluation of dual‐target inhibitors for the treatment of Alzheimer's disease	15
Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents	15
Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors	15
Cover Picture: Arch Pharm (6/2022)	15
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review	15
Novel tetrahydropyran‐triazole hybrids with antiproliferative activity against human tumor cells	15
Implication of Central β₂ Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease	15
Design, synthesis, and biological evaluation of simplified tetrahydroisoquinoline analogs	14
	14
5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates	14
Piperazine‐based P2X4 receptor antagonists	14
N‐[4‐(Benzyloxy)‐3‐methoxybenzyl)]adamantane‐1‐amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer	14
A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives	14
Cytotoxic derivatives of dichloroacetic acid and some metal complexes	14
Safe and selective anticancer agents from tetrafluorinated azobenzene‐imidazolium ionic liquids: Synthesis, characterization, and cytotoxic effects	14

Synthesis of new phenothiazine derivatives: Molecular docking, assessment of cytotoxic activity and oxidant–antioxidant properties on PCS‐201‐012, HT‐29, and SH‐SY5Y cell lines	14
Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action	14
Discovery of potent CSK inhibitors through integrated virtual screening and molecular dynamic simulation	13
Synthesis, Characterization and Evaluation of Antioxidant and Antimicrobial Activities of Novel Isatin Derivatives	13
Conjugates of amiridine and thiouracil derivatives as effective inhibitors of butyrylcholinesterase with the potential to block β‐amyloid aggregation	13
Quantum dots in the biomedical world: A smart advanced nanocarrier for multiple venues application	13
	13
Synthesis and evaluation of novel almazole D analogs as anticancer agents	13
Exploring the Antidiabetic Potential of Heterophylliin A From Elaeocarpus grandis	13
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents	13
Microwave‐assisted N‐alkylation of amines with alcohols catalyzed by MnCl₂: Anticancer, docking, and DFT studies	13
Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review	13
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity	13
	13
Cover Picture: Arch Pharm (6/2023)	13
Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential	13
New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents	13
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase	13
Identification of Novel β ‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy	13
	13
Issue Information: Arch Pharm (4/2025)	13
Review of β‐carboline and its derivatives as selective MAO‐A inhibitors	13
Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction	12
Synthesis of novel benzylamine antimycotics and evaluation of their antimycotic potency	12
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors	12
Unlocking the potential of edible Ulva sp. seaweeds: Metabolomic profiling, neuroprotective mechanisms, and implications for Parkinson's disease management	12
Design, synthesis, acetylcholinesterase, butyrylcholinesterase, and amyloid‐β aggregation inhibition studies of substituted 4,4ʹ‐diimine/4,4ʹ‐diazobiphenyl derivatives	12
Advances in polysaccharide‐based materials for biomedical and pharmaceutical applications: A comprehensive review	12
Synthesis, Antituberculosis Evaluation and Structure–Activity Relationships of New SQ109 Analogs	12
Design, Synthesis, and Molecular Evaluation of S_NAr‐Reactive N‐(6‐Fluoro‐3‐Nitropyridin‐2‐yl)Isoquinolin‐3‐Amines as Covalent USP7 Inhibitors Reveals an Unconventional Binding Mode	12
5,6‐Dihydrotetrazolo[1,5‐c]quinazolines: Toxicity prediction, synthesis, antimicrobial activity, molecular docking, and perspectives	12
Design, synthesis, and evaluation of novel 3,4‐isoxazolediamide derivatives for the combination treatment of azole‐resistant candidiasis	11
Synthesis and photodynamic activity of new 5‐[(E)‐2‐(3‐alkoxy‐1‐phenyl‐1H‐pyrazol‐4‐yl)ethenyl]‐2‐phenyl‐3H‐indoles	11
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes	11
Silybin loaded Ag‐nanoparticles as a drug delivery system for solid tumor theragnosis: Extraction, radioiodination, and biodistribution study	11
Current Scenario of Hydroxamic Acid Derivatives With In Vivo Antitumor Therapeutic Potential	11
	11
Editorial Board: Arch Pharm (9/2023)	11
The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens	11
Current Landscape of Hydroxamic Acid Hybrids With Anti‐Colorectal Cancer Potential	11
A new series of hydrazones as small‐molecule aldose reductase inhibitors	11
New PEPPSI‐Pd‐NHC complexes bearing 4‐hydroxyphenylethyl group: Synthesis, characterization, molecular docking, and bioactivity properties	11
Recent Advancements and Developments of Anti‐Malarial Agents Reported in 2023	11
Issue Information: Arch Pharm (4/2024)	11
Solvent and Catalyst‐Free One‐Pot Synthesis of Tetrahydropyrimidine Analogs for Their Larvicidal Activity and Structural Insights	11
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development	11
Screening of Chelidonium majus isoquinoline alkaloids reveals berberine and chelidonine as selective ligands for the nuclear receptors RORβ and HNF4α, respectively	11
Development of New Thiadiazole Derivatives as VEGFR‐2 Inhibitors With Anticancer and Proapoptotic Activities‏	11
A Multifaceted Mechanistic Approach to Assess the Inhibitory Potential of Broccoli‐Derived Glucosinolates Against Tumor‐Associated Carbonic Anhydrase IX	11
Tetrazole Derivatives as Multiclass Inhibitors of Bacterial Carbonic Anhydrases	11
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies	11
A virtual library of small molecules mimicking dipeptides	11
Ginkgo biloba in the management of the COVID‐19 severity	10
Synthesis, structure–activity relationship, and biological evaluation of quinolines for development of anticancer agents	10
New 1H‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors	10
Rational Design of 6‐Amino‐2‐Piperazinylpyridine‐Based ROCK2 Inhibitors With Anti‐Breast Cancer Metastatic Efficiency	10
An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020–2024)	10
Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration	10
A novel indole derivative, 2‐{3‐[1‐(benzylsulfonyl)piperidin‐4‐yl]‐2‐methyl‐1H‐indol‐1‐yl}‐1‐(pyrrolidin‐1‐yl)ethenone, suppresses hedgehog signaling and drug‐resistant tumor growth	10
Inhibitory effects of 190 compounds against SARS‐CoV‐2 M^pr^o protein: Molecular docking interactions	10
Structural Advances in Non‐Sulfonamide Carbonic Anhydrase Inhibitors: Insights Into Design, Bioactivity, and Binding Mechanism	10
ω‐(5‐Phenyl‐2H‐tetrazol‐2‐yl)alkyl‐substituted hydrazides and related compounds as inhibitors of amine oxidase copper containing 3 (AOC3)	10
Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors	10
	10
Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors	10
Тhio‐containing pteridines: Synthesis, modification, and biological activity	10
Design, synthesis of novel thiazole‐thiomorpholine derivatives and evaluation of their anticancer activity via in vitro and in silico studies	10
Greenness‐by‐design approach for developing novel UV spectrophotometric methodologies resolving a quaternary overlapping mixture	9
Design and synthesis of benzofuran‐ and naphthalene‐fused thiazinones as antimycobacterial agents	9
Structure Characterization and Antibacterial, Antifungal, and Antiquorum‐Sensing Activity of New Metabolites From the Lipophilic Fractions of Platycodon grandiflorum	9
The anti‐breast cancer potential of indole/isatin hybrids	9
Design, Synthesis, and Selective Antiproliferative Activity of Indolizine Derivatives as Microtubule Destabilizers	9
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells	9
Dihydropyrimidinones as potent anticancer agents: Insight into the structure–activity relationship	9
Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment	9
Issue Information: Arch Pharm (1/2025)	9
New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies	9
New 1,3,4‐Thiadiazole‐Based Dual B‐Raf/VEGFR‐2 Inhibitors With Potential Anti‐Breast Activity: Design, Synthesis, In Vitro and In Silico Evaluations	9
Targeting the binding pocket of the fluorophore 8‐anilinonaphthalene‐1‐sulfonic acid in the bacterial enzyme MurA	9
Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4‐oxadiazole derivatives: Synthesis, in vitro screening, and computational studies	9

Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking	9
Self‐microemulsifying drug delivery system‐based gastroretentive in situ raft of pazopanib with enhanced solubility and bioavailability	9
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions	9
New phenylthiosemicarbazide‐phenoxy‐1,2,3‐triazole‐N‐phenylacetamides as dual inhibitors against α‐glucosidase and PTP‐1B for the treatment of type 2 diabetes	9
Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4‐oxadiazole derivatives	9
Various pharmacological agents in the pipeline against intractable epilepsy	9
The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases	9
Metabolic profiling of Verbena bonariensis L. extract by LC/MS and evaluation of the hepatoprotective potential with isoniazid‐ and rifampicin‐induced hepatotoxicity in rats	9
Health benefits of fraxetin: From chemistry to medicine	9
3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists	9
1,3,4‐Thiadiazole and 1,2,4‐triazole‐5‐thione derivatives bearing 2‐pentyl‐5‐phenyl‐2,4‐dihydro‐3H‐1,2,4‐triazole‐3‐one ring: Synthesis, molecular docking, urease inhibition, and crystal struct	9
Research progress on the pathogenesis of psoriasis and its small molecule inhibitors	9
Eco‐friendly approaches to 1,3,4‐oxadiazole derivatives: A comprehensive review of green synthetic strategies	9
Proapoptotic effects of halogenated bis‐phenylthiourea derivatives in cancer cells	9
Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors	9
Issue Information: Arch Pharm (12/2024)	9
Synthesis, characterization, biochemical, and molecular modeling studies of carvacrol‐based new thiosemicarbazide and 1,3,4‐thiadiazole derivatives	9
Synthesis and evaluation of febrifugine derivatives as anticoccidial agents	8
Synthesis and biological evaluation of sulfonamide‐based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae	8
	8
Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier system	8
	8
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation	8
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluatio	8
Harnessing Fragment Merging and Chain Extension Approaches for Designing Phthalimidoalkyl‐Arylidene Thiazolidinedione Hybrids: New Frontiers in Apoptosis‐Inducing Cancer Treatment	8
Bruceantin and Brusatol: Molecular Insights and Therapeutic Promise of Quassinoids in Cancer Drug Discovery	8
Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities	8
Cover Picture: Arch Pharm (3/2022)	8
A review of recent advances in anticancer activity and SAR of pyrazole derivatives	8
In‐vitro and in‐silico investigations of SLC‐0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors	8
Cover Picture: Arch Pharm (1/2022)	8
Rational Design, Green Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Potent EGFR Inhibitors via One‐Pot Four‐Component Reaction	8
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects	8
Novel isoxazoline‐linked 1,3,4‐thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation	8
Recent green approaches for the synthesis of pyrazolo[3,4‐d]pyrimidines: A mini review	8
Emerging green synthetic routes for thiazole and its derivatives: Current perspectives	8
The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review	8
Combating Drug‐Resistant Protozoal Infections: A Review of Emerging Therapeutics	8
Editorial Board: Arch Pharm (9/2022)	8
Revealing a Gold Mine of Bioactive Compounds From Natural Sources Using In Vitro, In Silico, and Network Pharmacology: A Case Study on Cachrys cristata	8
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis	8
Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway	7
Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐b]pyridazine hybrid derivatives as VEGFR selective inhibitors	7
Design, Synthesis, and Biological Evaluation of Novel Benzimidazole/Schiff Base Hybrid Derivatives With Potential Biological Activities	7
Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics	7
New azaaurone derivatives as potential multitarget agents in HIV‐TB coinfection	7
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases	7
Editorial Board: Arch Pharm (6/2022)	7
Corrigendum to “Design, Synthesis, Biological Evaluation, and In Silico Studies of Quinoxaline Derivatives as Potent p38αMAPK Inhibitors”	7
4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator	7
Multi‐Angle Bioactivity Cartography for Computational Screening and Mechanistic Analysis of AChE Inhibitors From Yellow Gastrodia elata	7
Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway	7
Synthesis of selenophene‐based chalcone analogs and assessment of their biological activity as anticancer agents	7
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF^V600E with promising antiproliferative properties	7
Cover Picture: Arch Pharm (10/2023)	7
EGB761 ameliorates mild cognitive impairment by inhibiting the pyroptosis and apoptosis in both in vivo and in vitro experiments	7
	7
Development of fluorinated nicotinonitriles and fused candidates as antimicrobial, antibiofilm, and enzyme inhibitors	7
Quinolinone Derivatives Suppress Angiogenesis in Human Umbilical Vein Endothelial Cells by Blocking the VEGF‐Induced VEGFR2 Signaling Pathway	7
Synthesis of benzylated amine‐substituted xanthone derivatives and their antioxidant and anti‐inflammatory activities	7
Introduction to artificial intelligence and deep learning using interactive electronic programming notebooks	7
Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies	7
Cover Picture: Arch Pharm (8/2023)	7
Novel RP‐HPLC method for estimation of a newly developed combination of tizanidine and etoricoxib in rat plasma: Eight criteria for greens evaluation	7
Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential	7
Discovery of Furopyrimidine‐Pyrazole Hybrid Compounds Targeting p53‐MDM2 Interaction as Anticancer Agents	6
	6
2,2,2‐Trifluoroethanol‐mediated hydroarylation of fluorinated alkynes with indoles: Application to diindolylmethanes	6
The anti‐Acinetobacter baumannii therapeutic potential of azole hybrids: A mini‐review	6
Discovery of novel harmine derivatives as GSK‐3β/DYRK1A dual inhibitors for Alzheimer's disease treatment	6
Anti‐inflammatory activity of pyridazinones: A review	6
A Review on Curcumin: Pharmacological Promises and Biomedical Activities	6
Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells	6
Cardioprotective effect of silymarin nanoemulsion on 5‐fluorouracil‐induced cardiotoxicity in rats	6
Enhancing Polyacrylonitrile Nanofibers Antiviral Activity Using Greenly Synthesized Silver Nanoparticles	6
	6
Green synthesis of pregabalin‐stabilized gold nanoclusters and their applications in sensing and drug release	6
Synthesis of vanillin derivatives with 1,2,3‐triazole fragments and evaluation of their fungicide and fungistatic activities	6
Sequential Optimization Approach Toward an Azapeptide‐Based SARS‐CoV‐2 Main Protease Inhibitor	6
SiteMine: Large‐scale binding site similarity searching in protein structure databases	6
Synthesis of amide derivatives containing the imidazole moiety and evaluation of their anti‐cardiac fibrosis activity	6
Repurposing of 5‐nitrofuran‐3,5‐disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agents	6
1H‐1,2,3‐Triazole−4H‐chromene−D‐glucose hybrid compounds: Synthesis and inhibitory activity against Mycobacterium tuberculosis protein tyrosine phosphatase B	6
Novel Purine‐Based Natural Products as Inhibitors of Cholinesterases and Monoamine Oxidases Presenting Potential Multitarget Therapeutics Tackling Alzheimer's Disease	6
Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review	6
	6
Uro‐Protective Role of Lacosamide Against Cyclophosphamide‐Induced Cystitis via Notch1/NICD/NF‐ κ B Pathway: Network Pharmacology, Molecular Docking, and	6
Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease	6
Unraveling the chemical profile, antioxidant, enzyme inhibitory, cytotoxic potential of different extracts from Astragalus caraganae	6
Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation	6
Radiosynthesis and whole‐body distribution in mice of a ¹⁸F‐labeled azepino[4,3‐b]indole‐1‐one derivative with multimodal activity for the treatment of Alzheimer's disease	6
Potential of triazines in Alzheimer's disease: A versatile privileged scaffold	6
Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation	6
Design and synthesis of novel substituted s‐triazines tethered benzenesulfonamides as potential antimicrobial candidates: Antibiofilm and bacterial protein permeability assessments	6
Exploring Micellar Systems for Intra‐Articular Delivery of Vanillic Acid in Management of Osteoarthritis	6